1. Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck
   Tania Crombet Ramos et al, 2020, Frontiers in Oncology CrossRef
2. Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma
   Sadia Rahman et al, 2019, International Journal of Molecular Sciences CrossRef
3. Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
   Ming-Huei Chou et al, 2021, International Journal of Molecular Sciences CrossRef
4. Current Insights and Advancements in Head and Neck Cancer: Emerging Biomarkers and Therapeutics with Cues from Single Cell and 3D Model Omics Profiling
   Yashika Jawa et al, 2021, Frontiers in Oncology CrossRef
5. Novel 3-Methyleneisoindolinones Diversified via Intramolecular Heck Cyclization Induce Oxidative Stress, Decrease Mitochondrial Membrane Potential, Disrupt Cell Cycle, and Induce Apoptosis in Head and Neck Squamous Cell Carcinoma Cells
   Arti Sharma et al, 2022, ACS Omega CrossRef
6. The Potential of Tumor Debulking to Support Molecular Targeted Therapies
   Felix Oppel et al, 2020, Frontiers in Oncology CrossRef
7. Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma
   Yoshiaki Yura et al, 2020, Cancers CrossRef
8. Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies
   Yanping Li et al, 2022, Frontiers in Oncology CrossRef
9. Functional genomics screen with pooled shRNA library and gene expression profiling with extracts of Azadirachta indica identify potential pathways for therapeutic targets in head and neck squamous cell carcinoma
   Neeraja M. Krishnan et al, 2019, PeerJ CrossRef
10. Traditional Herbal Medicine Mediated Regulations during Head and Neck Carcinogenesis
    Xiang-Yun Lan et al, 2020, Biomolecules CrossRef
11. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment
    Laurel B. Darragh et al, 2019, Frontiers in Immunology CrossRef
12. Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials
    Lejla Mahmutović et al, 2021, Microorganisms CrossRef
13. Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck
    Bhamini Patel et al, 2021, Cancers CrossRef
14. Toward a Molecular Classification of the Head and Neck Squamous Cell Carcinoma
    Amalia Raluca Ceausu et al, 2021, Surgical Management of Head and Neck Pathologies CrossRef
15. Updates and Controversies in the Management of Head and Neck Malignancy
    Belayat Hossain Siddiquee, 2022, Head and Neck Surgery : Surgical Landmark and Dissection Guide CrossRef
16. Genetic alterations and clinical dimensions of oral cancer: a review
    Keerthana Karunakaran et al, 2020, Molecular Biology Reports CrossRef
17. Ex Vivo Culture Models to Indicate Therapy Response in Head and Neck Squamous Cell Carcinoma
    Imke Demers et al, 2020, Cells CrossRef
18. Cancer-Associated Fibroblasts Modulate Transcriptional Signatures Involved in Proliferation, Differentiation and Metastasis in Head and Neck Squamous Cell Carcinoma
    Emilia Wiechec et al, 2021, Cancers CrossRef
19. IMP3 Protein Overexpression Is Linked to Unfavorable Outcome in Laryngeal Squamous Cell Carcinoma
    Diana Maržić et al, 2021, Cancers CrossRef
20. Comparative analysis of a panel of biomarkers related to protein phosphatase 2A between laryngeal squamous cell carcinoma tissues and adjacent normal tissues
    Han-ying Wang et al, 2019, Journal of Zhejiang University-SCIENCE B CrossRef
21. Controlled Drug Delivery Systems for Oral Cancer Treatment—Current Status and Future Perspectives
    null Ketabat et al, 2019, Pharmaceutics CrossRef